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ABSTRACT 
Importance: The decline in physical performance that occurs in many older subjects is a strong 
predictor of falls, hospitalization, institutionalization and mortality. Polyphenols are bioactive 
compounds that may play a preventive role against physical performance decline due to their 
antioxidant and anti-inflammatory properties. 
Objective: To investigate the association between total urinary polyphenols (TUP) and total 
dietary polyphenols (TDP) and substantial physical performance decline over a nine-year period 
among older subjects. 
Methods: This longitudinal study included 368 participants aged 65 years or older from the 
InCHIANTI (Invecchiare in Chianti) study, an Italian population-based cohort. TUP and TDP 
concentrations were assessed at baseline using the Folin-Ciocalteau (F-C) assay and a validated 
food frequency questionnaire, respectively. Physical performance was objectively measured at 
baseline and at nine-year follow-up using the Short Physical Performance Battery (SPPB). A 
substantial decline in physical performance was considered as a decrease of three or more points 
in the SPPB score.  
Results: At the nine-year follow-up assessment, 71 participants had suffered a substantial decline 
in physical performance. In the fully adjusted logistic regression model, participants in the 
highest TUP tertile had a lower risk of substantial decline in physical performance than those in 
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the lowest tertile (OR, 0.40; 95% CI, 0.17–0.93; P trend=0.033). However, no significant 
association between TDP intake and physical performance decline was observed. 
Conclusion: This study shows that high TUP concentrations, a biomarker of polyphenol-rich 
exposure, were associated with lower risk of substantial decline in physical performance in 
community-dwelling older subjects over a nine-year period. These results suggest that a 
polyphenol-rich diet may play a role in protecting against physical performance decline in older 
people. 
 
INTRODUCTION 
The decline in physical performance that occurs in many older people often marks the early 
stage of a process leading to disability
(1)
 and is associated with increased morbidity and 
mortality
(2-4)
. The Short Physical Performance Battery (SPPB) is a standardized tool for 
assessing physical performance in both research and clinical geriatric settings
(5)
. It has an 
excellent reliability and is highly sensitive to clinically substantial changes, being a strong 
predictor of subsequent disability, nursing home admission, hospitalization and mortality in 
community-dwelling older subjects
(1, 4, 6)
. The causes of physical performance decline are 
complex and not completely understood. Aging, diseases and unhealthy life-style factors, 
mainly low physical activity and poor nutrition, can contribute to physical decline in older 
persons. There is increasing evidence suggesting that a healthy diet can reduce the risk of 
developing disability in older adults
(7, 8)
. A recent study on diet rich in fruits and vegetables, 
such as the Mediterranean diet, showed a beneficial role in mobility-related outcomes
(9, 10)
. 
Over the last few years, there has been an increasing interest in polyphenols, which are 
present in diets rich in fruits, vegetables and their derived products, due to their biological 
effects that could be beneficial to promote healthy aging, such as maintaining optimal 
physical and cognitive performance
(11)
. However, to the best of our knowledge, no 
epidemiological study has evaluated the association between total polyphenol intake and 
physical performance decline in older subjects. 
One of the reasons for the lack of studies in this field is the difficulty in assessing total 
dietary polyphenol (TDP) intake. This is mainly due to the well-known drawbacks of using 
self-reported dietary questionnaires and the limited food composition data on all 
polyphenol classes
(12)
. The use of a valid polyphenol biomarker, i.e. the concentration of 
total urinary polyphenols (TUP), provides a more accurate and objective measure of total 
polyphenol exposure than dietary questionnaires
(12)
. In a previous study by our group, TDP 
was moderately correlated with TUP, and it is currently utilized as biomarker of total 
polyphenol intake
(13)
. In the present study, our objective was to evaluate whether TUP 
concentrations and TDP intake were associated with a lower risk of physical performance 
decline over a nine-year follow-up in a community-dwelling older population. 
 
METHODS 
Study population 
The InCHIANTI (Invecchiare nel Chianti) is a prospective population-based study aimed at 
investigating the factors contributing to the decline of mobility in older subjects living in 
two municipalities located in Tuscany (Italy). A description of the study rationale, design 
and methods is provided in detail elsewhere
(14)
. The study population comprised 1,155 
participants aged 65–102 years, who were randomly selected from the residents’ registry 
with the use of a multistage stratified sampling method. The response rate was 91.6%. 
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Data collected at baseline (1998–2000) and during the nine-year follow-up assessment 
(2007–2009) were used for the current analyses. Participants with missing data at baseline 
on TUP (n=346, individuals without 24-h urine sample), SPPB at baseline (n=30) or SPPB 
at nine-year follow-up (n=408, of whom 126 had no physical performance assessment, 225 
died, 42 refused and 15 emigrated before the nine-year visit) were excluded. We also 
excluded participants with dementia at baseline (n=3), since they were not able to complete 
the questionnaires reliably
(9, 15)
. The final sample included 368 participants aged 65 years or 
older. 
 
Total polyphenol exposure 
At baseline, 24-h urine samples were obtained from participants. Urine samples were 
immediately aliquoted and stored at –80 ºC until analysis. Samples were thawed on ice and 
analysed using the Folin-Ciocalteau (F-C) assay after a solid-phase extraction, which 
allows the elimination of interfering substances that could react with the F-C assay, as 
described previously
(13)
. TUP concentrations were expressed as mg of gallic acid 
equivalents (GAE) per 24-h urine.  
A validated Italian version of food frequency questionnaire was self-administered to assess 
the intake of 236 food items (g/d) consumed in the preceding year
(16)
. TDP intake was 
estimated using a food composition database on polyphenols
(17)
 based on three USDA 
databases
(18-20)
 and the Phenol-Explorer database
(21)
. TDP intake was calculated as the sum 
of flavonoids (anthocyanidins, flavonols, flavanones, flavones, flavanols and isoflavones), 
phenolic acids, lignans, stilbenes and other polyphenols expressed as aglycone equivalents 
(mg/d)
(21)
. 
 
Short Physical Performance Battery (SPPB) 
Physical performance was assessed at baseline and at nine-year follow-up using the SPPB, 
which comprises three different tests
(4)
: 4-metre walking speed, ability to rise from a chair, 
and standing balance in progressively more challenging positions. Each test has a score 
ranging from 0 to 4, with a value of 0 indicating inability to complete the test and 4 being 
the highest level of performance
(1)
. The final score, which is the sum of the score in each of 
the three tests, ranges from 0 (worst performance) to 12 (best performance). A substantial 
decline in physical performance was defined as a decrease of three or more points in the 
SPPB score
(22, 23) 
over the nine years of follow-up. 
 
Baseline covariates 
Smoking status was self-reported and participants were classified as “current smokers” and 
“non-smokers” (including former and never smokers). Anthropometric measures were 
taken by trained personnel and body mass index (BMI) was calculated as weight/height
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(kg/m
2
). Educational level was recorded as the number of years of schooling. Physical 
activity in the previous year was self-reported and classified as
(24)
: 1) sedentary (completely 
inactive or light-intensity physical activity, i.e., walking), 2) light (light-intensity physical 
activity for 2 to 4 h/wk), and 3) moderate to intense (light-intensity physical activity of at 
least >4 h/wk or moderate-intensity physical activity of at least 1–2 h/wk). Dietary intakes 
of total energy (kcal/d) and alcohol (g/d) were estimated using an Italian food composition 
table
(25)
. Medications were coded according to the Anatomical Therapeutic Chemical 
Codes
(26)
. Diseases were ascertained by information from self-reported physician 
diagnoses, pharmacological treatments, medical history, clinical examinations and blood 
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tests. Renal function was classified as normal renal function (≥60 mL/min) and impaired 
renal function (<60 mL/min) using the Cockcroft-Gault formula
(27): (140−Age) x Weight x 
[0.85 if female] / (72 x Serum Creatinine). Cognitive function was assessed by the Mini-
Mental State Examination (MMSE). Participants with a MMSE score <24 were considered 
to be cognitively impaired
(28)
. Depressive symptoms were assessed using the Center for 
Epidemiological Studies Depression Scale (CES-D). A score of ≥20 was used to identify 
clinically relevant depressive symptoms
(29)
. Functional status was evaluated using the 
Katz’s Activities of Daily Living (ADL) (0-6)(30), and the Lawton and Brody for the 
Instrumental Activities of Daily Living (IADL) (0-8) scales
(31)
. 
 
Statistical analysis 
Descriptive analyses were conducted to provide information on baseline characteristics of 
the study population. Comparisons were calculated using age-adjusted generalized linear 
models. We analysed the associations between TUP and TDP and physical performance 
decline using two different statistical approaches: 1) Associations between TDP and TUP 
and substantial decline in physical performance over nine years of follow-up (difference ≥ 
three points in SPPB score between nine-year follow-up and baseline, dichotomous 
variable) were analysed using logistic regression models. 2) Associations between TDP and 
TUP and decline in SPPB score (continuous variable) over nine years of follow-up were 
estimated using multivariable linear regression models. TUPs and TDPs were categorized 
as tertiles according to the following cut-off: 133 and 185 mg GAE/d, and 494 and 640 
mg/d, respectively. Tests for linear trend were performed by considering the median of 
each tertile as an ordinal variable. TUP and TDP were analysed after a log2 transformation, 
since they were not normally distributed. Covariates in these statistical models were 
identified a priori as known risk factors or potential confounders and were included at the 
same time. Three separate statistical models were performed: model 1, adjusted for age and 
gender; model 2, additionally adjusted for baseline SPPB score (in order to correct for the 
“regression toward the mean”); and model 3, further adjusted for education, physical 
activity, current smoking, BMI, number of medications, energy and alcohol intakes, renal 
impairment, diabetes, hypertension, stroke, cognitive impairment and depressed mood. 
Interactions with gender, age, BMI, smoking status, physical activity, cognitive impairment 
and depressed mood were tested between TUP and TDP levels and SPPB score by 
including product terms in the fully adjusted model. There was no evidence of collinearity. 
In the sensitivity analysis, we excluded participants if they had an extreme energy intake 
(participant in the top or the bottom 1% of the distribution of the reported total energy 
intake) in models for TDP. In a second sensitivity analysis, participants with an extreme 
change in SPPB score, considered as a change of ≥9 points in the SPPB score over the 9 
years of follow-up, were excluded in TUP and TDP models. All analyses were performed 
using the SPSS package program version 20.0 (SPSS, Chicago, IL). Two-tailed P<0.05 was 
considered statistically significant. 
 
 
 
 
  
5 
 
 
RESULTS 
Table 1 provides the baseline characteristics of the population sample according to tertiles 
of TUP and TDP, adjusted for age. The mean (SD) age of the participants was 71.3 (4.8) 
years and 54.1% were female. From the highest to the lowest tertiles of TUP, participants 
were likely to be older, took fewer medications and had lower BMI. Moreover, from the 
highest to the lowest tertiles of TDP, participants were likely to be older and women, less 
sedentary, had lower alcohol and energy intake, and had a higher prevalence of stroke and 
disability in more than one IADL. The change in SPPB score over the nine-year follow-up 
ranged from -12 to 4, with a mean (SD) change of -1.9 (3.1). Two hundred and thirteen 
(57.9%) participants suffered a decline in SPPB score, of whom 71 (19.3%) experienced a 
substantial decline in physical performance (a decrease of three or more points in the SPPB 
score). Participants with substantial physical performance decline over the 9-years of 
follow-up were older and more likely to be women, had a lower physical activity, daily 
alcohol intake, total urinary polyphenols and had a higher prevalence of depressed mood 
and cognitive impairment than those without a substantial physical performance decline 
(Supplementary table 1). Participants not included in the current study (n=787) were 
significantly older, more likely to be disabled, had poorer cognitive function, lower 
physical activity and higher depressed mood (all P<0.05) than those included in the study.  
The Spearman correlation between TUP and TDP at baseline was 0.140 (P<0.001). The 
median (IQR) of TDP intake decreased during the follow-up being 556 (462-682), 539 
(429-656), 513 (415-619) and 500 (407-595) mg/day, at baseline, three-, six-, and nine-year 
follow-up visits, respectively. The Spearman correlations of TDP intake at baseline with 
TDP at three-, six-, and nine-year follow-up visits were 0.50 (P<0.001), 0.41 (P<0.001), 
and 0.35 (P<0.001), respectively. The difference in the intake of TDP was mainly due to a 
decrease in the consumption of fruits (279mg/d at baseline and 189mg/d after 9-y of 
follow-up) and vegetables (187g/d at baseline and 143g/d after 9-y of follow-up); while the 
intakes of total energy and macronutrients were stable along the 9 years of follow-up. 
The association between TUP and TDP concentrations and substantial decline in physical 
performance over the nine-year follow-up is shown in Table 2. In logistic regression 
models adjusted for age and gender, participants in the highest tertile of TUP had a 
significant lower risk of substantial decline in physical performance than those in the 
lowest tertile (OR = 0.38; 95% CI = 0.18–0.80; P trend = 0.011). This association remained 
statistically significant after the adjustment for baseline SPPB score (OR = 0.38; 95% CI = 
0.18–0.80; P trend = 0.011) and potential confounders (OR = 0.40; 95% CI = 0.17–0.93; P 
trend = 0.033). No association between TDP intake and substantial decline in physical 
performance was observed.  
The associations between TDP and TUP concentrations and the decline in SPPB score at 
nine years of follow-up are presented in Table 3. In general linear models adjusted for age 
and gender, participants in the highest TUP tertile were associated with a significant lower 
decline of physical performance [mean difference (95% CI) comparing extreme tertiles, 
0.99 (0.25–1.73), P trend = 0.008]. Further adjustment for baseline score and potential 
confounding factors did not change considerably the risk estimates [mean difference (95% 
CI) comparing extreme tertiles, 0.97 (0.23–1.70), P trend = 0.009] and [mean difference 
(95% CI) comparing extreme tertiles, 0.98 (0.23–1.73), P trend = 0.009], respectively. No 
association between TDP intake and decline in SPPB score was found.  
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We did not observe any statistically significant interactions between TUP and TDP 
concentrations and physical performance, using either of the two approaches, by gender, 
age, BMI, smoking status, physical activity and depressed mood interactions (all P 
values>0.05).  
Sensitivity analyses were performed by repeating the models after the exclusion of 
participants in the top or bottom 1% of the distribution of total energy intake for TDP 
(n=8). The associations between TDP intake and physical performance decline were non-
significant and almost identical to results based on the whole population (data not shown). 
After the exclusion of 25 participants with extreme changes in SPPB score, the association 
between TUP and decline in physical performance was attenuated but still statistically 
significant (OR for log2 = 0.49; 95% CI = 0.07-0.90). 
 
DISCUSSION 
This prospective study shows that older people with high TUP concentrations, a nutritional 
biomarker of polyphenol exposure
(13)
, had a lower risk of substantial decline in physical 
performance over a nine-year follow-up. In addition, high TUP concentrations were 
significantly associated with a lower physical performance decline These results were 
clinically relevant since the difference in SPPB score was almost 1 point comparing 
participants in the extreme TUP tertiles
(32-33)
. No association was found with TDP, 
analogously to what was observed in our previous InCHIANTI studies regarding all-cause 
mortality
(17)
, substantial cognitive decline
(34)
, and frailty syndrome
(35)
. These differences in 
the results between TUP and TDP could be due to bioavailability and interactions of 
polyphenols with other compounds, such as caffeine
(36)
. Thus, TUP measurement takes into 
account polyphenol bioavailability that highly varies between and within subjects
(37)
. 
Greater adherence to the Mediterranean diet was associated with a lower decline in body 
mobility over time and a lower risk of developing mobility disability in community-living 
older adults
(9)
. Mediterranean diet is associated with an adequate intake of certain nutrients 
with antioxidant capacity (such as vitamins and polyphenols), which has been related to a 
reduced risk of physical performance impairment in older subjects
(7)
. Several 
epidemiological studies have suggested protective associations between polyphenols and 
some age-related chronic diseases, and even total mortality
(17, 34-35, 38-42)
. These beneficial 
activities, which may be attributable to their ability to modulate oxidative stress and 
subsequent inflammation
(43-44)
, can translate in a protective effect against the development 
of physical performance decline. However, to date limited data exists on the potential 
effects of total polyphenol intake on skeletal muscle. Sarcopenia, a degenerative loss of 
skeletal muscle mass and strength associated with aging, is a major determinant of physical 
performance decline
(45)
. A recent study has demonstrated that polyphenols are able to 
totally restore muscle maximal mitochondrial oxidative capacity, and decrease skeletal 
muscle ROS (reactive oxygen species) production in association with an enhancement of 
antioxidant defence in aging animals
(46)
. Some polyphenols such as resveratrol also activate 
SIRT1 (sirtuin 1), leading to modulation of muscle gene expression and improving 
mitochondrial function
(47)
.  
Major strengths of this study included its prospective design and the selection of the 
participants among community-living older men and women. Another major strength was 
the measure of a validated biomarker, TUP concentrations in 24-h urine samples, to assess 
polyphenol exposure
(13)
. A further advantage was the use of a standardized and objective 
assessment test (the SPPB) to evaluate decline in physical performance. Finally, our models 
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were constructed taking into account potentially confounding variables of physical 
performance decline and polyphenol exposure; however, possible residual confounding 
cannot be excluded. 
The present study also has some limitations. First, the number of subjects who suffered a 
substantial decline in physical performance was relatively small. However, this is the first 
prospective cohort study, with a reasonable sample size, to investigate the relationship 
between polyphenol exposure (TUP and TDP) and physical performance decline. Second, 
TUP was measured only once at baseline. Although there was a decrease in the polyphenol 
intake during the follow-up as in other studies with aging 
(48)
, we were interested in the 
long-term predicting ability of polyphenol exposure in the physical performance decline. 
Third, the TDP intake may be underestimated, although the dietary intake was assessed 
using a validated country-specific FFQ
(16) 
and a comprehensive database on polyphenols
(17, 
34-35)
. 
In conclusion, the current longitudinal study shows that higher concentrations of TUP, a 
nutritional biomarker of polyphenol-rich exposure, were associated with a lower risk of 
substantial decline in physical performance in older subjects living in a community. A 
polyphenol-rich diet seems to play an important preventive role against physical 
performance decline, and therefore in the delay of the onset of disability. 
 
ACKNOWLEDGEMENTS 
The InCHIANTI study was supported in part by the Italian Ministry of Health and by the 
U.S. National Institute on Aging (NIA). The authors are grateful for support granted by 
Spanish government grants from the Ministry of Economy and Competitiveness 
(MINECO) and cofounded by the FEDER (Fondo Europeo de Desarrollo Regional): the 
CONSOLIDER-INGENIO 2010 program, FUN-C-FOOD (CSD2007-063), and the JPI 
HDHL FOODBALL (PCIN-2014-133). We also thank the award of 2014SGR1566 from 
the Generalitat de Catalunya’s Agency AGAUR. Partially funded by the International Nut 
and Dried Fruit Council Foundation (INC) in collaboration with the Bosch i Gimpera 
Foundation (FBG307906). M.U.-S. would like to thank the “Ramón y Cajal” program 
(RYC-2011-09677) from MINECO and the Fondo Social Europeo. 
 
AUTHOR CONTRIBUTIONS 
The authors’ contributions to the manuscript were as follows: CA-L, LF, SB, and AC 
designed the research; MR, RZ-R, CA-L and AC conducted the research; MR, CA-L and 
MU-S performed the samples analyses; MR and RZ-R conducted the statistical analysis; 
MR wrote the manuscript; RZ-R, AC, CA-L, MU-S, LF and SB provided critical revision, 
and CA-L and AC had primary responsibility for the final content. All authors read and 
approved the final manuscript. 
 
CONFLICT OF INTEREST 
None of the authors had any financial or personal conflicts of interest. 
8 
 
REFERENCES 
1. Guralnik JM, Ferrucci L, Simonsick EM, et al. (1995) Lower-extremity function in 
persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 
332, 556-561. 
2. Cooper R, Kuh D, Cooper C, et al. (2011) Objective measures of physical capability 
and subsequent health: a systematic review. Age Ageing 40, 14-23. 
3. Cooper R, Kuh D, Hardy R, et al. (2010) Objectively measured physical capability 
levels and mortality: systematic review and meta-analysis. BMJ 341:c4467. 
4. Guralnik JM, Simonsick EM, Ferrucci L, et al. (1994) A short physical performance 
battery assessing lower extremity function: association with self-reported disability and 
prediction of mortality and nursing home admission. J Gerontol 49, M85-94. 
5. Applegate WB, Blass JP, Williams TF. (1990) Instruments for the functional 
assessment of older patients. N Engl J Med 322, 1207-1214. 
6. Ostir GV, Volpato S, Fried LP, et al. (2002) Reliability and sensitivity to change 
assessed for a summary measure of lower body function: results from the Women's 
Health and Aging Study. J Clin Epidemiol 55, 916-21. 
7. Milaneschi Y, Tanaka T, Ferrucci L. (2010) Nutritional determinants of mobility. 
Curr Opin Clin Nutr Metab Care 13, 625-629. 
8. May AM, Struijk EA, Fransen HP,et al. (2015) The impact of a healthy lifestyle on 
Disability-Adjusted Life Years: a prospective cohort study. BMC Med 13, 287. 
9. Milaneschi Y, Bandinelli S, Corsi AM, et al. (2011) Mediterranean diet and mobility 
decline in older persons. Exp Gerontol 46, 303-308. 
10. Zbeida M, Goldsmith R, Shimony T, et al. (2014) Mediterranean diet and 
functional indicators among older adults in non-Mediterranean and Mediterranean 
countries. J Nutr Health Aging 18, 411-418. 
11. Pallauf K, Giller K, Huebbe P, et al. (2013) Nutrition and healthy ageing: calorie 
restriction or polyphenol-rich "MediterrAsian" diet? Oxid Med Cell Longev 2013, 
707421. 
12. Zamora-Ros R, Rabassa M, Llorach R, et al. (2012) Application of Dietary 
Phenolic Biomarkers in Epidemiology: Past, Present, and Future. J Agric Food Chem 
60, 6648-6657. 
13. Zamora-Ros R, Rabassa M, Cherubini A, et al. (2011) Comparison of 24-h 
volume and creatinine-corrected total urinary polyphenol as a biomarker of total dietary 
polyphenols in the Invecchiare InCHIANTI study. Anal Chim Acta 704, 110-115. 
14. Ferrucci L, Bandinelli S, Benvenuti E, et al. (2000) Subsystems contributing to 
the decline in ability to walk: bridging the gap between epidemiology and geriatric 
practice in the InCHIANTI study. J Am Geriatr Soc 48, 1618-1625. 
15. Zuniga K, McAuley E. (2015) Considerations in selection of diet assessment 
methods for examining the effect of nutrition on cognition. J Nutr Health Aging 19, 
333-340 
16. Pisani P, Faggiano F, Krogh V, et al. (1997) Relative validity and 
reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC 
centres. Int J Epidemiol 26 Suppl 1, S152-S160. 
17. Zamora-Ros R, Rabassa M, Cherubini A, et al. (2013) High concentrations of a 
urinary biomarker of polyphenol intake are associated with decreased mortality in older 
adults. J Nutr 143, 1445-1450. 
18. U. S. Department of Agriculture. (2008) Database for the Isoflavone Content of 
Selected foods. USDA. Beltsville: MD. 
19. U. S. Department of Agriculture. (2004) Database for the Proanthocyanidin 
Content of Selected foods. USDA. Beltsville: MD. 
9 
 
20. U.S. Department of Agriculture. (2011) Database for the Flavonoid Content of 
Selected Foods. USDA. Beltsville: MD. 
21. Neveu V, Perez-Jimenez J, Vos F, et al. (2010) Phenol-Explorer: an online 
comprehensive database on polyphenol contents in foods. Database (Oxford) 2010, 
bap024. 
22. Milaneschi Y, Bandinelli S, Corsi AM, et al. (2010) Personal mastery and lower 
body mobility in community-dwelling older persons: the Invecchiare in Chianti study. J 
Am Geriatr Soc 58, 98-103. 
23. Penninx BW, Guralnik JM, Ferrucci L, et al. (1998) Depressive symptoms and 
physical decline in community-dwelling older persons. JAMA 279, 1720-1726. 
24. Ainsworth BE, Haskell WL, Leon AS, et al. (1993) Compendium of physical 
activities: classification of energy costs of human physical activities. Med Sci Sports 
Exerc 25, 71-80. 
25. Salvini S. (1997) A food composition database for epidemiological studies in 
Italy. Cancer Lett 114, 299-300. 
26. Pahor M, Chrischilles EA, Guralnik JM, et al. (1994) Drug data coding and 
analysis in epidemiologic studies. Eur J Epidemiol 10, 405-411. 
27. Cockcroft DW, Gault MH. (1976) Prediction of creatinine clearance from serum 
creatinine. Nephron 16, 31-41. 
28. Folstein MF, Folstein SE, McHugh PR. (1975) "Mini-mental state". A practical 
method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 
189-198. 
29. Beekman AT, Deeg DJ, Van Limbeek J, et al. (1997) Criterion validity of the 
Center for Epidemiologic Studies Depression scale (CES-D): results from a community-
based sample of older subjects in The Netherlands. Psychol Med 27, 231-235. 
30. Katz S, Ford AB, Moskowitz RW, et al. (1963) Studies of Illness in the Aged. 
The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. 
JAMA 185, 914-919. 
31. Lawton MP, Brody EM. (1969) Assessment of older people: self-maintaining 
and instrumental activities of daily living. Gerontologist 9, 179-186. 
32. Kwon S, Perera S, Pahor M, et al. (2009) What is a meaningful change in 
physical performance? Findings from a clinical trial in older adults (the LIFE-P study). 
J Nutr Health Aging 13:538-544. 
33. Perera S, Mody SH, Woodman RC, et al. (2006) Meaninful change and  
responsiveness in common physical performance measures in older adults. J Am Geriatr 
Soc 54:743-749. 
34. Rabassa M, Cherubini A, Zamora-Ros R, et al. (2015) Low Levels of a Urinary 
Biomarker of Dietary Polyphenol are Associated with Substantial Cognitive Decline 
Over a 3-Year Period in Older Adults: The Invecchiare in Chianti Study. J Am Geriatr 
Soc 63, 938-946. 
35. Urpi-Sarda M, Andres-Lacueva C, Rabassa M, et al. (2015) The Relationship 
Between Urinary Total Polyphenols and the Frailty Phenotype in a Community-
Dwelling Older Population: The InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 
doi: 10.1093/gerona/glv026. In press. 
36. Gramza-Michałowska A. (2014) Caffeine in tea camellia sinensis--content, 
absorption, benefits and risks of consumption. J Nutr Health Aging 18, 143-149. 
37. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and 
bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J 
Clin Nutr 81, 230S-242S. 
10 
 
38. Cassidy A, Mukamal KJ, Liu L, et al. (2013) High anthocyanin intake is 
associated with a reduced risk of myocardial infarction in young and middle-aged 
women. Circulation 127, 188-196. 
39. van Dam RM, Naidoo N, Landberg R. (2013) Dietary flavonoids and the 
development of type 2 diabetes and cardiovascular diseases: review of recent findings. 
Curr Opin Lipidol 24, 25-33. 
40. Geybels MS, Verhage BAJ, Arts IC, et al. (2013) Dietary Flavonoid Intake, 
Black Tea Consumption, and Risk of Overall and Advanced Stage Prostate Cancer. Am 
J Epidemiol 177, 1388-1398. 
41. Zamora-Ros R, Jimenez C, Cleries R, et al. (2013) Dietary flavonoid and lignan 
intake and mortality in a Spanish cohort. Epidemiology 24, 726-733. 
42. Zamora-Ros R, Forouhi NG, Sharp SJ, et al. (2013) The Association Between 
Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European 
Populations: The EPIC-InterAct Study. Diabetes care 36, 3961-3970. 
43. Obrenovich ME, Nair NG, Beyaz A, et al. (2010) The role of polyphenolic 
antioxidants in health, disease, and aging. Rejuvenation Res 13, 631-643. 
44. Uysal U, Seremet S, Lamping JW, et al. (2013) Consumption of polyphenol 
plants may slow aging and associated diseases. Curr Pharm Des 19, 6094-6111. 
45. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. (2008) Sarcopenia: its 
assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health 
Aging 12, 433-450. 
46. Charles AL, Meyer A, Dal-Ros S, et al. (2013) Polyphenols prevent ageing-
related impairment in skeletal muscle mitochondrial function through decreased reactive 
oxygen species production. Exp Physiol 98, 536-545. 
47. Chung S, Yao H, Caito S, et al. (2010) Regulation of SIRT1 in cellular 
functions: role of polyphenols. Arch Biochem Biophys 501, 79-90. 
48. Grosso G, Stepaniak U, Topor-Mądry R, et al. (2014) Estimated dietary intake 
and major food sources of polyphenols in the Polish arm of the HAPIEE study. 
Nutrition 30, 1398-1403. 
11 
 
Table 1: Characteristics of the study participants 65 years or older at baseline according to tertiles of TUP and TDP 
    TDP   TUP 
Characteristic All  Tertile 1  Tertile 2 Tertile 3  P
†
   Tertile 1  Tertile 2 Tertile 3  P
*
 
n (% of study population) 368 (100) 122 (33.2) 123 (33.4) 123 (33.4) 
  
122 (33.2) 123 (33.4) 123 (33.4) 
 
Age, mean (SD), years 71.3 (4.8) 72.1 (5.6) 70.9 (4.2) 70.8 (4.6) 0.028 
 
71.9 (4.9) 71.8 (5.5) 70.1 (3.8) 0.006 
Female gender, n (%) 199 (54.1) 81 (66.4) 69 (56.1) 49 (39.8) <0.001 
 
69 (56.6) 67 (54.5) 63 (51.2) 0.55 
BMI, mean (SD), kg/m
2
  27.6 (3.7) 27.2 (4.1) 27.9 (3.7) 27.6 (3.4) 0.60 
 
26.8 (3.7) 27.8 (3.7) 28.2 (3.7) 0.008 
Education, mean (SD), 
years 
6.2 (3.6) 5.8 (3.3) 6.4 (3.6) 6.5 (3.8) 0.20 
 
6.1 (3.5) 6.3 (3.9) 6.2 (3.3) 0.85 
Physical activity, n (%)  
    
0.010 
 
   
0.71 
  Sedentary 27 (7.4) 14 (11.5) 9 (7.3) 4 (3.3) 
 
 
10 (8.2) 10 (8.3) 7 (5.7) 
   Light 174 (47.5) 63 (51.6) 59 (48.0) 52 (43.0) 
 
 
61 (50.0) 56 (46.3) 57 (46.3) 
   Moderate to high 165 (45.1) 45 (36.9) 55 (44.7) 65 (53.7) 
 
 
51 (41.8) 55 (45.5) 59 (48.0) 
 Current smoker, n (%) 48 (13.0) 13 (10.7) 17 (13.8) 18 (14.6) 0.44 
 
14 (11.5) 16 (13.0) 18 (14.6) 0.59 
Number of medications, 
mean (SD) 
2.0 (1.8) 2.2 (1.9) 1.9 (1.8) 1.9 (1.8) 0.43 
 
1.5 (1.4) 2.2 (1.9) 2.2 (2.0) <0.001 
Daily total energy intake, 
mean (SD), kcal/d 
1972 (577) 
1654.0 
(441.8) 
1936.6 
(470.1) 
2321.2 
(600.5) 
<0.001 
 
1922 (539) 1974 (618) 2018 (571) 0.44 
Alcohol intake, mean (SD), 
g/d 
16.5 (23.4) 10.2 (14.8) 16.0 (21.7) 23.1 (29.6) <0.001 
 
16.8 (24.7) 15.4 (24.2) 17.3 (21.4) 0.96 
TUP, mg GAE/d 
161 (122-
203) 
146 (115-
190) 
166 (120-
209) 
163 (129-
212) 
0.024 
 
107 (87-
122) 
160 (145-
171) 
223 (202-
251) 
<0.001 
TDP, mg/d 
556 (462-
683) 
418 (328-
462) 
555 (521-
597) 
762 (683-
823) 
<0.001 
 
529 (462-
662) 
533 (445-
690) 
592 (486-
698) 
0.73 
Renal impairment, n (%) 200 (54.3) 72 (59.0) 66 (53.7) 62 (50.4) 0.52 
 
77 (63.1) 63 (51.2) 60 (48.8) 0.19 
Stroke, n (%) 12 (3.3) 7 (5.7) 4 (3.3) 1 (0.8) 0.035 
 
3 (2.5) 3 (2.4) 6 (4.9) 0.27 
Hypertension, n (%) 173 (47.0) 60 (49.2) 58 (47.2) 55 (44.7) 0.63 
 
61 (50.0) 58 (47.2) 54 (43.9) 0.51 
12 
 
Diabetes Mellitus, n (%) 48 (13.0) 17 (13.9) 17 (13.8) 14 (11.4) 0.57 
 
11 (9.0) 16 (13.0) 21 (17.1) 0.05 
Depressed mood, CES-D 
score ≥ 20, n (%) 
58 (15.8) 24 (19.7) 17 (13.8) 17 (13.8) 0.28 
 
25 (20.5) 20 (16.3) 13 (10.6) 0.07 
Cognitive impairment, 
MMSE score < 24, n (%) 
55 (14.9) 24 (19.7) 12 (9.8) 19 (15.4) 0.77 
 
21 (17.2) 19 (15.4) 15 (12.2) 0.96 
ADL disability, n (%) 3 (0.8) 3 (2.5) 0 (0.0) 0 (0.0) >0.99 
 
1 (0.8) 2 (1.6) 0 (0.0) 0.51 
IADL disability, n (%) 24 (6.5) 16 (13.1) 6 (4.9) 2 (1.6) 0.001   10 (8.2) 7 (5.7) 7 (5.7) 0.75 
SPPB score, mean (SD) 11.2 (1.3) 11.2 (1.3) 11.1 (1.5) 11.2 (1.2) 0.51  11.0 (1.6) 11.3 (1.1) 11.3 (1.4) 0.27 
Change in SPPB score, 
mean (SD) 
-1.9 (3.1) -2.3 (3.4) -1.5 (2.9) -1.9 (3.1) 0.81  -2.5 (3.5) -2.2 (3.2) -1.1 (2.3) 0.007 
Substantial SPPB decline, n 
(%) 
71 (19.3) 31 (25.4) 17 (13.8) 23 (18.7) 0.52  33 (27.0) 26 (21.1) 12 (9.8) 0.009 
Abbreviations: TUP, total urinary polyphenols; GAE, gallic acid equivalents; TDP, total dietary polyphenols; BMI, body mass index; CES-D, 
center for epidemiologic studies depression scale; MMSE, Mini-Mental State Examination; ADL, activities of daily living; IADL, instrumental 
activities of daily living. 
Generalized linear models were adjusted for age, except when age is the evaluated characteristic. 
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Table 2. Logistic regression models evaluating the association of total urinary and dietary polyphenols with substantial decline of 
physical performance 
  TDP  
 
TUP  
  Cut-off n OR (95% CI) P-value   Cut-off n OR (95% CI) P-value 
 
mg/d 
 
 
 
 
mg GAE/d 
 
 
 
Model 1
*
 
   
 
    
 
Tertile 1 <494 31 1 (reference)  
 
<133 33 1 (reference)  
Tertile 2 494-640 17 0.61 (0.30–1.23) 0.16 
 
133-185 26 0.70 (0.37–1.32) 0.27 
Tertile 3 >640 23 0.98 (0.50–1.94) 0.96 
 
>185 12 0.38 (0.18–0.81) 0.012 
P trend
†
 
  
0.95  
   
0.012  
Continuous (log2)  
71 0.80 (0.43–1.47) 0.46 
  
71 0.52 (0.32–0.87) 0.012 
Model 2
‡
 
   
 
    
 
Tertile 1 <494 31 1 (reference)  
 
<133 33 1 (reference)  
Tertile 2 494-640 17 0.61 (0.30–1.24) 0.18 
 
133-185 26 0.69 (0.36–1.31) 0.26 
Tertile 3 >640 23 0.99 (0.50–1.95) 0.97 
 
>185 12 0.38 (0.18–0.80) 0.011 
P trend
†
 
  
0.93  
   
0.011  
Continuous (log2) 
 
71 0.80 (0.43–1.48) 0.48 
  
71 0.52 (0.32–0.87) 0.012 
Model 3
§
 
  
 
    
 
Tertile 1 <494 31 1 (reference)  
 
<133 33 1 (reference)  
Tertile 2 494-640 17 0.76 (0.36–1.64) 0.48 
 
133-185 26 0.70 (0.34–1.42) 0.32 
Tertile 3 >640 23 1.12 (0.49–2.55) 0.79 
 
>185 12 0.40 (0.17–0.93) 0.034 
P trend
†
 
  
0.74  
   
0.033  
Continuous (log2)  
71 0.81 (0.38–1.71) 0.58   
 
71 0.51 (0.29–0.90) 0.021 
Abbreviations: TDP, total dietary polyphenols; TUP, total urinary polyphenols; OR, odds ratio; CI, confidence interval; GAE, gallic acid 
equivalents. 
*
Adjusted for age and gender. 
†
P trend obtained by assigning the median of each tertile as ordinal variable. 
‡
Adjusted for age, gender and baseline SPPB score. 
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§
Fully adjusted for age, gender, baseline SPPB score, education, physical activity, current smoking, BMI, number of medications, energy and 
alcohol intakes, renal impairment, diabetes, hypertension, stroke, cognitive impairment and depressed mood.  
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Table 3. Multivariable linear regression models testing the association between TUP and TDP and change in physical performance over 
nine years of follow-up 
  TDP  
 
TUP  
 
Cut-off Mean difference (95% CI) P-value  Cut-off Mean difference (95% CI) P-value 
 mg/d    mg GAE/d   
Model 1
*
 
  
 
   
 
Lowest tertile  <494 1 (reference) 
 
 
<133 1 (reference) 
 
Intermediate tertile 494-640 0.47 (-0.26–1.21) 
0.21 
 133-185 0.29 (-0.44–1.02) 
0.44 
Highest tertile >640 -0.05 (-0.80–0.71) 
0.90 
 >185 0.99 (0.25–1.73) 
0.009 
P trend
†
 
 
0.76  
  
0.008  
Continuous (log2)
‡
  0.35 (-0.29–0.99) 0.28   0.70 (0.15–1.24) 0.012 
Model 2
§
 
  
 
   
 
Lowest tertile  <494 1 (reference) 
 
 
<133 1 (reference) 
 
Intermediate tertile 494-640 0.51 (-0.23–1.24) 
0.18 
 133-185 0.27 (-0.46–1.00) 
0.47 
Highest tertile >640 -0.04 (-0.80–0.71) 
0.91 
 >185 0.97 (0.23–1.70) 
0.010 
P trend
†
 
 
0.76  
  
0.009  
Continuous (log2)
‡
  0.37 (-0.26–1.01) 0.26   0.70 (0.15–1.24) 0.012 
Model 3
ǁ
 
 
 
   
 
Lowest tertile  <494 1 (reference) 
 
 
<133 1 (reference) 
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Intermediate tertile 494-640 0.32 (-0.42–1.06) 
0.40 
 133-185 0.29 (-0.44–1.03) 
0.43 
Highest tertile >640 -0.20 (-1.03–0.62) 
0.63 
 >185 0.98 (0.23–1.73) 
0.010 
P trend
†
 
 
0.54  
  
0.009  
Continuous (log2)
‡
  0.41 (-0.32–1.13) 0.27   0.74 (0.19–1.30) 0.009 
Abbreviations: TDP, total dietary polyphenols; TUP, total urinary polyphenols; CI, confidence interval; GAE, gallic acid equivalents. 
*
Adjusted for age and gender. 
†
P trend obtained by assigning the median of each tertile as ordinal variable. 
‡
Non-standardized regression coefficient (95% CI). 
§
Adjusted for age, gender and baseline SPPB score. 
ǁ
Fully adjusted for age, gender, baseline SPPB score, education, physical activity, current smoking, BMI, number of medications, daily energy 
and alcohol intakes, renal impairment, diabetes, hypertension, stroke, cognitive impairment and depressed mood.
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Supplementary table 1. Baseline characteristics of the study participants according to 
presence or absence of substantial physical performance decline over 9 years of follow-up. 
Characteristic
*
 
No substantial 
physical 
performance 
decline 
Substantial 
physical 
performance 
decline 
P-value
†
 
(n=297) (n=71) 
Age, years 70.4 (4.3) 74.8 (5.3) <0.001 
Female gender 151 (50.8) 48 (67.6) 0.043 
BMI, kg/m
2
  27.8 (3.6) 26.7 (4.0) 0.11 
Education, years 6.4 (3.5) 5..4 (3.5) 0.3 
Physical activity  
  
0.012 
   Sedentary 17 (5.8) 10 (14.1) 
    Light 133 (45.1) 41 (57.7) 
    Moderate to high 145 (49.2) 20 (28.2) 
 Current smoker 40 (13.5) 8 (11.3) 0.88 
Number of medications 1.9 (1.8) 2.5 (2.0) 0.48 
Daily caloric intake, kcal/d 2004.2 (592.5) 1834.3 (485.5) 0.3 
Alcohol intake, g/d 18.3 (24.9) 8.9 (13.4) 0.005 
TUP, mg GAE/d 165 (127-208) 135 (108-166) 0.013 
TDP, mg/d 557 (465-688) 529 (455-669) 0.26 
Renal impairment 148 (49.8) 52 (73.2) 0.15 
Stroke 9 (3.0) 3 (4.2) 0.65 
Hypertension 131 (44.1) 42 (59.2) 0.08 
Diabetes Mellitus 37 (12.5) 11 (15.5) 0.61 
Depressed mood, CES-D score ≥ 20 38 (12.8) 20 (28.2) 0.015 
Cognitive impairment, MMSE score < 24 29 (9.8) 26 (36.6) 0.001 
Number of ADL disabilities 1 (0.3) 2 (2.8) 0.08 
Number of IADL disabilities 14 (4.7) 10 (14.1) 0.12 
*
Variables reported as means (SD), percentages or median (IQR) as appropriate. 
†
Generalized linear models were adjusted for age, except when age is the evaluated 
characteristic. 
 
